Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Journal of Antimicrobial Chemotherapy | journal | 1.902 Q1 | 221 | 583 | 1558 | 13684 | 6869 | 1238 | 4.29 | 23.47 |  |
| 2 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 136 | 294 | 6496 | 1149 | 263 | 4.07 | 47.76 | |
| 3 | Alimentary Pharmacology and Therapeutics | journal | 1.786 Q1 | 207 | 320 | 1151 | 11429 | 5368 | 1036 | 4.90 | 35.72 | |
| 4 | Rheumatology | journal | 1.764 Q1 | 198 | 476 | 1338 | 11699 | 4986 | 904 | 3.70 | 24.58 | |
| 5 | Orphanet Journal of Rare Diseases | journal | 1.749 Q1 | 136 | 29 | 135 | 1594 | 908 | 134 | 7.62 | 54.97 | |
| 6 | Cochrane Database of Systematic Reviews | journal | 1.651 Q1 | 327 | 1327 | 2773 | 75812 | 12919 | 2772 | 4.01 | 57.13 | |
| 7 | Antiviral Therapy | journal | 1.619 Q1 | 93 | 134 | 418 | 4995 | 1651 | 411 | 4.07 | 37.28 | |
| 8 | HIV Medicine | journal | 1.583 Q1 | 86 | 98 | 277 | 2704 | 996 | 261 | 3.30 | 27.59 | |
| 9 | Clinical Pharmacokinetics | journal | 1.494 Q1 | 184 | 60 | 212 | 4237 | 1153 | 202 | 5.36 | 70.62 | |
| 10 | Drug Safety | journal | 1.384 Q1 | 140 | 99 | 305 | 5046 | 1257 | 257 | 3.88 | 50.97 | |
| 11 | Journal of Psychopharmacology | journal | 1.378 Q1 | 135 | 128 | 394 | 5266 | 1272 | 343 | 2.82 | 41.14 | |
| 12 | Pharmacoepidemiology and Drug Safety | journal | 1.363 Q1 | 109 | 169 | 460 | 4639 | 1229 | 398 | 2.60 | 27.45 | |
| 13 | Pharmaceutical Statistics | journal | 1.283 Q1 | 46 | 32 | 90 | 745 | 133 | 79 | 1.59 | 23.28 | |
| 14 | Drugs | journal | 1.273 Q1 | 188 | 167 | 636 | 13257 | 2707 | 504 | 5.12 | 79.38 | |
| 15 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | |
| 16 | CNS Drugs | journal | 1.217 Q1 | 129 | 86 | 250 | 6860 | 1085 | 221 | 4.47 | 79.77 | |
| 17 | British Journal of Clinical Pharmacology | journal | 1.187 Q1 | 167 | 216 | 725 | 6383 | 2305 | 558 | 3.02 | 29.55 | |
| 18 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
| 19 | AIDS Research and Therapy | journal | 1.112 Q1 | 49 | 30 | 82 | 891 | 210 | 82 | 2.81 | 29.70 | |
| 20 | Trials | journal | 1.088 Q1 | 98 | 124 | 139 | 4196 | 334 | 131 | 2.36 | 33.84 | |
| 21 | PLoS Clinical Trials | journal | 1.017 Q1 | 14 | 0 | 25 | 0 | 65 | 22 | 2.71 | 0.00 | |
| 22 | Journal of Biomedical Science | journal | 0.982 Q1 | 110 | 113 | 234 | 5075 | 558 | 230 | 2.23 | 44.91 | |
| 23 | Cardiovascular Therapeutics | journal | 0.927 Q1 | 54 | 37 | 32 | 1698 | 93 | 28 | 2.91 | 45.89 | |
| 24 | Expert Review of Anticancer Therapy | journal | 0.895 Q2 | 85 | 166 | 539 | 11461 | 1262 | 492 | 2.40 | 69.04 | |
| 25 | HIV Clinical Trials | journal | 0.888 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 26 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 | |
| 27 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.848 Q2 | 57 | 38 | 98 | 1324 | 219 | 94 | 2.27 | 34.84 | |
| 28 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 | |
| 29 | American Journal of Cardiovascular Drugs | journal | 0.796 Q2 | 60 | 43 | 134 | 2160 | 338 | 128 | 2.63 | 50.23 | |
| 30 | Expert Opinion on Drug Safety | journal | 0.779 Q2 | 90 | 68 | 240 | 5545 | 673 | 192 | 2.84 | 81.54 | |
| 31 | Expert Review of Neurotherapeutics | journal | 0.775 Q2 | 98 | 147 | 519 | 13586 | 1289 | 466 | 2.49 | 92.42 | |
| 32 | Human Psychopharmacology | journal | 0.758 Q2 | 86 | 75 | 212 | 3679 | 540 | 204 | 2.56 | 49.05 | |
| 33 | Drugs and Aging | journal | 0.749 Q2 | 109 | 90 | 248 | 5633 | 659 | 236 | 3.01 | 62.59 | |
| 34 | Fundamental and Clinical Pharmacology | journal | 0.707 Q2 | 85 | 90 | 228 | 3924 | 546 | 222 | 2.37 | 43.60 | |
| 35 | Paediatric Drugs | journal | 0.700 Q2 | 70 | 52 | 137 | 2363 | 324 | 108 | 2.42 | 45.44 | |
| 36 | Acta Pharmacologica Sinica | journal | 0.624 Q2 | 117 | 199 | 659 | 8200 | 1233 | 657 | 1.81 | 41.21 | |
| 37 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.622 Q2 | 81 | 90 | 264 | 2551 | 578 | 242 | 2.03 | 28.34 | |
| 38 | BMC Pharmacology | journal | 0.620 Q2 | 48 | 19 | 53 | 530 | 96 | 53 | 1.41 | 27.89 | |
| 39 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | |
| 40 | BMC Clinical Pharmacology | journal | 0.599 Q2 | 43 | 19 | 34 | 679 | 84 | 34 | 2.46 | 35.74 | |
| 41 | International Journal of STD and AIDS | journal | 0.542 Q2 | 78 | 247 | 751 | 4520 | 882 | 651 | 1.12 | 18.30 | |
| 42 | Advances in Antiviral Drug Design | book series | 0.523 Q2 | 12 | 0 | 7 | 0 | 14 | 6 | 2.00 | 0.00 | |
| 43 | Clinical Drug Investigation | journal | 0.513 Q2 | 67 | 93 | 252 | 2659 | 472 | 244 | 1.79 | 28.59 | |
| 44 | Therapeutic Advances in Cardiovascular Disease | journal | 0.512 Q2 | 41 | 43 | 55 | 2499 | 97 | 49 | 1.76 | 58.12 | |
| 45 | Therapeutic Advances in Respiratory Disease | journal | 0.490 Q2 | 50 | 34 | 44 | 1571 | 83 | 41 | 1.89 | 46.21 | |
| 46 | European Journal of Contraception and Reproductive Health Care | journal | 0.410 Q2 | 53 | 63 | 178 | 1362 | 189 | 165 | 1.09 | 21.62 | |
| 47 | Journal of Chemotherapy | journal | 0.393 Q2 | 56 | 131 | 448 | 3318 | 459 | 401 | 1.15 | 25.33 | |
| 48 | Biopharmaceutics and Drug Disposition | journal | 0.369 Q2 | 65 | 52 | 164 | 1637 | 263 | 164 | 1.46 | 31.48 | |
| 49 | Journal of Oncology Pharmacy Practice | journal | 0.323 Q3 | 44 | 34 | 91 | 861 | 88 | 84 | 0.81 | 25.32 | |
| 50 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.247 Q3 | 61 | 69 | 195 | 2369 | 96 | 172 | 0.57 | 34.33 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data